世界のヒトパピローマウイルス感染症治療薬市場レポート2020年

【英語タイトル】Global Human Papillomavirus Infection Drug Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB6749)・商品コード:QYR21FB6749
・発行会社(調査会社):QYResearch
・発行日:2021年1月
・ページ数:148
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,120,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界のヒトパピローマウイルス感染症治療薬市場について種類別(治療薬ターゲット、インターフェロン、RNA干渉ベース治療法、天然・ハーブ誘導体)、用途別(小売薬局、病院薬局、オンライン薬局)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ヒトパピローマウイルス感染症治療薬市場の概要
・世界の主要地域別ヒトパピローマウイルス感染症治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のヒトパピローマウイルス感染症治療薬市場規模2015-2026:種類別(治療薬ターゲット、インターフェロン、RNA干渉ベース治療法、天然・ハーブ誘導体)
・世界のヒトパピローマウイルス感染症治療薬市場規模2015-2026:用途別(小売薬局、病院薬局、オンライン薬局)
・ヒトパピローマウイルス感染症治療薬のアメリカ市場規模2015-2020
・ヒトパピローマウイルス感染症治療薬のヨーロッパ市場規模2015-2020
・ヒトパピローマウイルス感染症治療薬の中国市場規模2015-2020
・ヒトパピローマウイルス感染症治療薬の日本市場規模2015-2020
・ヒトパピローマウイルス感染症治療薬の東南アジア市場規模2015-2020
・ヒトパピローマウイルス感染症治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・ヒトパピローマウイルス感染症治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・ヒトパピローマウイルス感染症治療薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Human Papillomavirus Infection Drug Market
The global Human Papillomavirus Infection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Human Papillomavirus Infection Drug Scope and Market Size
The global Human Papillomavirus Infection Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus Infection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Human Papillomavirus Infection Drug market is segmented into
Therapeutic Drugs Targets
Interferon
RNA Interference based Therapies
Natural and Herbal Derivatives

Segment by Application, the Human Papillomavirus Infection Drug market is segmented into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

The Human Papillomavirus Infection Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Papillomavirus Infection Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Human Papillomavirus Infection Drug Market Share Analysis
Human Papillomavirus Infection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Papillomavirus Infection Drug business, the date to enter into the Human Papillomavirus Infection Drug market, Human Papillomavirus Infection Drug product introduction, recent developments, etc.

The major vendors covered:
Merck
Aclaris Therapeutics
Mylan Pharmaceuticals
Biogen Idec
Lees Pharmaceutical Holdings
MedImmune
Novan
Inovio Pharmaceuticals
Cutanea Life Sciences
Hemispherx
ISA Pharmaceuticals
Nielsen BioSciences

【レポートの目次】

1 Human Papillomavirus Infection Drug Market Overview
1.1 Human Papillomavirus Infection Drug Product Scope
1.2 Human Papillomavirus Infection Drug Segment by Type
1.2.1 Global Human Papillomavirus Infection Drug Sales by Type (2020-2026)
1.2.2 Therapeutic Drugs Targets
1.2.3 Interferon
1.2.4 RNA Interference based Therapies
1.2.5 Natural and Herbal Derivatives
1.3 Human Papillomavirus Infection Drug Segment by Application
1.3.1 Global Human Papillomavirus Infection Drug Sales Comparison by Application (2020-2026)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Human Papillomavirus Infection Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Papillomavirus Infection Drug Sales Growth Rate (2015-2026)
1.4.2 Global Human Papillomavirus Infection Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Papillomavirus Infection Drug Price Trends (2015-2026)

2 Human Papillomavirus Infection Drug Estimate and Forecast by Region
2.1 Global Human Papillomavirus Infection Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Papillomavirus Infection Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Papillomavirus Infection Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Human Papillomavirus Infection Drug Revenue Market Share by Region (2015-2020)
2.3 Global Human Papillomavirus Infection Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Papillomavirus Infection Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Papillomavirus Infection Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Papillomavirus Infection Drug Estimates and Projections (2015-2026)
2.4.2 Europe Human Papillomavirus Infection Drug Estimates and Projections (2015-2026)
2.4.3 China Human Papillomavirus Infection Drug Estimates and Projections (2015-2026)
2.4.4 Japan Human Papillomavirus Infection Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Papillomavirus Infection Drug Estimates and Projections (2015-2026)
2.4.6 India Human Papillomavirus Infection Drug Estimates and Projections (2015-2026)
3 Global Human Papillomavirus Infection Drug Competition Landscape by Players
3.1 Global Top Human Papillomavirus Infection Drug Players by Sales (2015-2020)
3.2 Global Top Human Papillomavirus Infection Drug Players by Revenue (2015-2020)
3.3 Global Human Papillomavirus Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus Infection Drug as of 2019)
3.4 Global Human Papillomavirus Infection Drug Average Price by Company (2015-2020)
3.5 Manufacturers Human Papillomavirus Infection Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Papillomavirus Infection Drug Players (Opinion Leaders)
4 Global Human Papillomavirus Infection Drug Market Size by Type
4.1 Global Human Papillomavirus Infection Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Human Papillomavirus Infection Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Papillomavirus Infection Drug Price by Type (2015-2020)
4.2 Global Human Papillomavirus Infection Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Papillomavirus Infection Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Human Papillomavirus Infection Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Papillomavirus Infection Drug Price Forecast by Type (2021-2026)
5 Global Human Papillomavirus Infection Drug Market Size by Application
5.1 Global Human Papillomavirus Infection Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Human Papillomavirus Infection Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Papillomavirus Infection Drug Price by Application (2015-2020)
5.2 Global Human Papillomavirus Infection Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Papillomavirus Infection Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Human Papillomavirus Infection Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Papillomavirus Infection Drug Price Forecast by Application (2021-2026)

6 United States Human Papillomavirus Infection Drug Market Facts & Figures
6.1 United States Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
6.2 United States Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
6.3 United States Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)

7 Europe Human Papillomavirus Infection Drug Market Facts & Figures
7.1 Europe Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
7.2 Europe Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
7.3 Europe Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)

8 China Human Papillomavirus Infection Drug Market Facts & Figures
8.1 China Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
8.2 China Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
8.3 China Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)

9 Japan Human Papillomavirus Infection Drug Market Facts & Figures
9.1 Japan Human Papillomavirus Infection Drug Sales Market Share by Company (3015-3030)
9.2 Japan Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
9.3 Japan Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)

10 Southeast Asia Human Papillomavirus Infection Drug Market Facts & Figures
10.1 Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)

11 India Human Papillomavirus Infection Drug Market Facts & Figures
11.1 India Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
11.2 India Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
11.3 India Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Human Papillomavirus Infection Drug Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Human Papillomavirus Infection Drug Products Offered
12.1.5 Merck Recent Development
12.2 Aclaris Therapeutics
12.2.1 Aclaris Therapeutics Corporation Information
12.2.2 Aclaris Therapeutics Business Overview
12.2.3 Aclaris Therapeutics Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Aclaris Therapeutics Human Papillomavirus Infection Drug Products Offered
12.2.5 Aclaris Therapeutics Recent Development
12.3 Mylan Pharmaceuticals
12.3.1 Mylan Pharmaceuticals Corporation Information
12.3.2 Mylan Pharmaceuticals Business Overview
12.3.3 Mylan Pharmaceuticals Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Pharmaceuticals Human Papillomavirus Infection Drug Products Offered
12.3.5 Mylan Pharmaceuticals Recent Development
12.4 Biogen Idec
12.4.1 Biogen Idec Corporation Information
12.4.2 Biogen Idec Business Overview
12.4.3 Biogen Idec Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biogen Idec Human Papillomavirus Infection Drug Products Offered
12.4.5 Biogen Idec Recent Development
12.5 Lees Pharmaceutical Holdings
12.5.1 Lees Pharmaceutical Holdings Corporation Information
12.5.2 Lees Pharmaceutical Holdings Business Overview
12.5.3 Lees Pharmaceutical Holdings Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lees Pharmaceutical Holdings Human Papillomavirus Infection Drug Products Offered
12.5.5 Lees Pharmaceutical Holdings Recent Development
12.6 MedImmune
12.6.1 MedImmune Corporation Information
12.6.2 MedImmune Business Overview
12.6.3 MedImmune Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 MedImmune Human Papillomavirus Infection Drug Products Offered
12.6.5 MedImmune Recent Development
12.7 Novan
12.7.1 Novan Corporation Information
12.7.2 Novan Business Overview
12.7.3 Novan Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novan Human Papillomavirus Infection Drug Products Offered
12.7.5 Novan Recent Development
12.8 Inovio Pharmaceuticals
12.8.1 Inovio Pharmaceuticals Corporation Information
12.8.2 Inovio Pharmaceuticals Business Overview
12.8.3 Inovio Pharmaceuticals Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Inovio Pharmaceuticals Human Papillomavirus Infection Drug Products Offered
12.8.5 Inovio Pharmaceuticals Recent Development
12.9 Cutanea Life Sciences
12.9.1 Cutanea Life Sciences Corporation Information
12.9.2 Cutanea Life Sciences Business Overview
12.9.3 Cutanea Life Sciences Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Cutanea Life Sciences Human Papillomavirus Infection Drug Products Offered
12.9.5 Cutanea Life Sciences Recent Development
12.10 Hemispherx
12.10.1 Hemispherx Corporation Information
12.10.2 Hemispherx Business Overview
12.10.3 Hemispherx Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hemispherx Human Papillomavirus Infection Drug Products Offered
12.10.5 Hemispherx Recent Development
12.11 ISA Pharmaceuticals
12.11.1 ISA Pharmaceuticals Corporation Information
12.11.2 ISA Pharmaceuticals Business Overview
12.11.3 ISA Pharmaceuticals Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 ISA Pharmaceuticals Human Papillomavirus Infection Drug Products Offered
12.11.5 ISA Pharmaceuticals Recent Development
12.12 Nielsen BioSciences
12.12.1 Nielsen BioSciences Corporation Information
12.12.2 Nielsen BioSciences Business Overview
12.12.3 Nielsen BioSciences Human Papillomavirus Infection Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Nielsen BioSciences Human Papillomavirus Infection Drug Products Offered
12.12.5 Nielsen BioSciences Recent Development

13 Human Papillomavirus Infection Drug Manufacturing Cost Analysis
13.1 Human Papillomavirus Infection Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Papillomavirus Infection Drug
13.4 Human Papillomavirus Infection Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Papillomavirus Infection Drug Distributors List
14.3 Human Papillomavirus Infection Drug Customers

15 Market Dynamics
15.1 Human Papillomavirus Infection Drug Market Trends
15.2 Human Papillomavirus Infection Drug Opportunities and Drivers
15.3 Human Papillomavirus Infection Drug Market Challenges
15.4 Human Papillomavirus Infection Drug Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Human Papillomavirus Infection Drug Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Human Papillomavirus Infection Drug Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Human Papillomavirus Infection Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Human Papillomavirus Infection Drug Sales (MT) by Region (2015-2020)
Table 5. Global Human Papillomavirus Infection Drug Sales Market Share by Region (2015-2020)
Table 6. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Human Papillomavirus Infection Drug Revenue Share by Region (2015-2020)
Table 8. Global Human Papillomavirus Infection Drug Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Human Papillomavirus Infection Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Human Papillomavirus Infection Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Human Papillomavirus Infection Drug (MT) of Key Companies (2015-2020)
Table 13. Global Human Papillomavirus Infection Drug Sales Share by Company (2015-2020)
Table 14. Global Human Papillomavirus Infection Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Human Papillomavirus Infection Drug Revenue Share by Company (2015-2020)
Table 16. Global Human Papillomavirus Infection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus Infection Drug as of 2019)
Table 17. Global Human Papillomavirus Infection Drug Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Human Papillomavirus Infection Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Human Papillomavirus Infection Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Human Papillomavirus Infection Drug Players
Table 22. Global Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 23. Global Human Papillomavirus Infection Drug Sales Share by Type (2015-2020)
Table 24. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Human Papillomavirus Infection Drug Price (MT) by Type (2015-2020)
Table 26. Global Human Papillomavirus Infection Drug Sales Share by Type (2021-2026)
Table 27. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Human Papillomavirus Infection Drug Revenue Share by Type (2021-2026)
Table 29. Global Human Papillomavirus Infection Drug Price (MT) by Type (2021-2026)
Table 30. Global Human Papillomavirus Infection Drug Sales (MT) by Application (2015-2020)
Table 31. Global Human Papillomavirus Infection Drug Sales Share by Application (2015-2020)
Table 32. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Human Papillomavirus Infection Drug Price (MT) by Application (2015-2020)
Table 34. Global Human Papillomavirus Infection Drug Sales (MT) by Application (2021-2026)
Table 35. Global Human Papillomavirus Infection Drug Sales Share by Application (2021-2026)
Table 36. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Human Papillomavirus Infection Drug Revenue Share by Application (2021-2026)
Table 38. Global Human Papillomavirus Infection Drug Price (MT) by Application (2021-2026)
Table 39. United States Human Papillomavirus Infection Drug Sales (MT) by Company (2015-2020)
Table 40. United States Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
Table 41. United States Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 42. United States Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 43. United States Human Papillomavirus Infection Drug Sales (MT) by Application (2015-2020)
Table 44. United States Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Human Papillomavirus Infection Drug Sales (MT) by Company (2015-2020)
Table 46. Europe Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 48. Europe Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Human Papillomavirus Infection Drug Sales (MT) by Application (2015-2020)
Table 50. Europe Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 51. China Human Papillomavirus Infection Drug Sales (MT) by Company (2015-2020)
Table 52. China Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
Table 53. China Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 54. China Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 55. China Human Papillomavirus Infection Drug Sales (MT) by Application (2015-2020)
Table 56. China Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Human Papillomavirus Infection Drug Sales (MT) by Company (2015-2020)
Table 58. Japan Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 60. Japan Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Human Papillomavirus Infection Drug Sales (MT) by Application (2015-2020)
Table 62. Japan Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Human Papillomavirus Infection Drug Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)
Table 69. India Human Papillomavirus Infection Drug Sales (MT) by Company (2015-2020)
Table 70. India Human Papillomavirus Infection Drug Sales Market Share by Company (2015-2020)
Table 71. India Human Papillomavirus Infection Drug Sales (MT) by Type (2015-2020)
Table 72. India Human Papillomavirus Infection Drug Sales Market Share by Type (2015-2020)
Table 73. India Human Papillomavirus Infection Drug Sales (MT) by Application (2015-2020)
Table 74. India Human Papillomavirus Infection Drug Sales Market Share by Application (2015-2020)
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. Merck Human Papillomavirus Infection Drug Product
Table 79. Merck Recent Development
Table 80. Aclaris Therapeutics Corporation Information
Table 81. Aclaris Therapeutics Description and Business Overview
Table 82. Aclaris Therapeutics Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Aclaris Therapeutics Human Papillomavirus Infection Drug Product
Table 84. Aclaris Therapeutics Recent Development
Table 85. Mylan Pharmaceuticals Corporation Information
Table 86. Mylan Pharmaceuticals Description and Business Overview
Table 87. Mylan Pharmaceuticals Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Mylan Pharmaceuticals Human Papillomavirus Infection Drug Product
Table 89. Mylan Pharmaceuticals Recent Development
Table 90. Biogen Idec Corporation Information
Table 91. Biogen Idec Description and Business Overview
Table 92. Biogen Idec Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Biogen Idec Human Papillomavirus Infection Drug Product
Table 94. Biogen Idec Recent Development
Table 95. Lees Pharmaceutical Holdings Corporation Information
Table 96. Lees Pharmaceutical Holdings Description and Business Overview
Table 97. Lees Pharmaceutical Holdings Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Lees Pharmaceutical Holdings Human Papillomavirus Infection Drug Product
Table 99. Lees Pharmaceutical Holdings Recent Development
Table 100. MedImmune Corporation Information
Table 101. MedImmune Description and Business Overview
Table 102. MedImmune Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. MedImmune Human Papillomavirus Infection Drug Product
Table 104. MedImmune Recent Development
Table 105. Novan Corporation Information
Table 106. Novan Description and Business Overview
Table 107. Novan Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Novan Human Papillomavirus Infection Drug Product
Table 109. Novan Recent Development
Table 110. Inovio Pharmaceuticals Corporation Information
Table 111. Inovio Pharmaceuticals Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Inovio Pharmaceuticals Description and Business Overview
Table 113. Inovio Pharmaceuticals Human Papillomavirus Infection Drug Product
Table 114. Inovio Pharmaceuticals Recent Development
Table 115. Cutanea Life Sciences Corporation Information
Table 116. Cutanea Life Sciences Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Cutanea Life Sciences Description and Business Overview
Table 118. Cutanea Life Sciences Human Papillomavirus Infection Drug Product
Table 119. Cutanea Life Sciences Recent Development
Table 120. Hemispherx Corporation Information
Table 121. Hemispherx Description and Business Overview
Table 122. Hemispherx Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Hemispherx Human Papillomavirus Infection Drug Product
Table 124. Hemispherx Recent Development
Table 125. ISA Pharmaceuticals Corporation Information
Table 126. ISA Pharmaceuticals Description and Business Overview
Table 127. ISA Pharmaceuticals Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. ISA Pharmaceuticals Human Papillomavirus Infection Drug Product
Table 129. ISA Pharmaceuticals Recent Development
Table 130. Nielsen BioSciences Corporation Information
Table 131. Nielsen BioSciences Description and Business Overview
Table 132. Nielsen BioSciences Human Papillomavirus Infection Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Nielsen BioSciences Human Papillomavirus Infection Drug Product
Table 134. Nielsen BioSciences Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Human Papillomavirus Infection Drug Distributors List
Table 138. Human Papillomavirus Infection Drug Customers List
Table 139. Human Papillomavirus Infection Drug Market Key Trends
Table 140. Human Papillomavirus Infection Drug Key Opportunities and Drivers
Table 141. Human Papillomavirus Infection Drug Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Infection Drug Product Picture
Figure 2. Global Human Papillomavirus Infection Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Papillomavirus Infection Drug Market Share by Application in 2020 & 2026
Figure 6. Retail Pharmacies Examples
Figure 7. Hospital Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Human Papillomavirus Infection Drug Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Human Papillomavirus Infection Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Human Papillomavirus Infection Drug Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Human Papillomavirus Infection Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Human Papillomavirus Infection Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Human Papillomavirus Infection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Human Papillomavirus Infection Drug Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Human Papillomavirus Infection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Human Papillomavirus Infection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Human Papillomavirus Infection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Human Papillomavirus Infection Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Human Papillomavirus Infection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Human Papillomavirus Infection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Human Papillomavirus Infection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Human Papillomavirus Infection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Human Papillomavirus Infection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Human Papillomavirus Infection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Human Papillomavirus Infection Drug Players Market Share by Revenue in Human Papillomavirus Infection Drug 2015 & 2019
Figure 27. Human Papillomavirus Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Human Papillomavirus Infection Drug Revenue Share by Type (2015-2020)
Figure 29. Global Human Papillomavirus Infection Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Human Papillomavirus Infection Drug Revenue Share by Application (2015-2020)
Figure 31. Global Human Papillomavirus Infection Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 33. United States Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 34. Europe Human Papillomavirus Infection Drug Sales Market Share by Company in 2019
Figure 35. Europe Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 36. Europe Human Papillomavirus Infection Drug Sales Market Share by Application in 2019
Figure 37. China Human Papillomavirus Infection Drug Sales Market Share by Company in 2019
Figure 38. China Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 39. China Human Papillomavirus Infection Drug Sales Market Share by Application in 2019
Figure 40. Japan Human Papillomavirus Infection Drug Sales Market Share by Company in 2019
Figure 41. Japan Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 42. Japan Human Papillomavirus Infection Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Human Papillomavirus Infection Drug Sales Market Share by Application in 2019
Figure 46. India Human Papillomavirus Infection Drug Sales Market Share by Company in 2019
Figure 47. India Human Papillomavirus Infection Drug Sales Market Share by Type in 2019
Figure 48. India Human Papillomavirus Infection Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Human Papillomavirus Infection Drug
Figure 51. Manufacturing Process Analysis of Human Papillomavirus Infection Drug
Figure 52. Human Papillomavirus Infection Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


【掲載企業】

Merck、Aclaris Therapeutics、Mylan Pharmaceuticals、Biogen Idec、Lees Pharmaceutical Holdings、MedImmune、Novan、Inovio Pharmaceuticals、Cutanea Life Sciences、Hemispherx、ISA Pharmaceuticals、Nielsen BioSciences

★調査レポート[世界のヒトパピローマウイルス感染症治療薬市場レポート2020年] (コード:QYR21FB6749)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒトパピローマウイルス感染症治療薬市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆